Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
2012 · New England Journal of Medicine · 7,903 citations
https://doi.org/10.1056/nejmoa1200694
A
Ashok Gupta
NIMS University(IN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
450
Papers
38.7K
Citations
49
h-index
162
i10-index
Ashok Gupta is an academic researcher from NIMS University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Cytokine Signaling Pathways and Interactions. The author has an h-index of 49, co-authored 383 publications.
Papers by this author
worksSafety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
2016 · Journal of Clinical Oncology · 840 citations
https://doi.org/10.1200/jco.2016.67.9761
Relapsing polychondritis: clinical presentations, disease activity and outcomes
2014 · Orphanet Journal of Rare Diseases · 38 citations
https://doi.org/10.1186/s13023-014-0198-1
Traumatic optic neuropathy in pediatric population: Early intervention or delayed intervention?
2007 · International Journal of Pediatric Otorhinolaryngology · 33 citations
https://doi.org/10.1016/j.ijporl.2006.11.018
Is fungal infestation of paranasal sinuses more aggressive in pediatric population?
2005 · International Journal of Pediatric Otorhinolaryngology · 32 citations
https://doi.org/10.1016/j.ijporl.2005.08.014
Serum-based protein biomarkers of bladder cancer: A pre- and post-operative evaluation
2016 · Journal of Pharmaceutical and Biomedical Analysis · 28 citations
https://doi.org/10.1016/j.jpba.2016.02.026
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat